New legislation would allow for reimbursement of prescribed digital therapeutics under Medicare, which proponents argue could increase access to these emerging treatments. Still, others say it's new technology, and the wrong reimbursement model could tamper innovation and increase patient costs.
The Access to Prescription Digital Therapeutics Act of 2022, introduced in the U.S. Senate in March...
